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Abstract 
According to a study, in 2018, it was estimated that the global market for topical products valued 
at over 9 billion dollars in 2014, which is only increasing. The load of treating these wounds is 
growing rapidly due to many different issues. These issues may include health care costs, and 
aging population. Another issue that has been growing over the years especially in the United 
States is a rise in the number of patients with diabetes and obesity. Currently there are some 
treatments that can deal with wound healing which include antibiotics, ointments, band-aids, etc. 
The basic steps of wound healing are homeostasis, inflammation, growth and rebuilding and 
strengthening. Within minutes or even seconds, the blood cells start to clump together and create 
a clot. This project aims to design and produce a new and renovated hydrogel. This new hydrogel 
will provide an additional amount of oxygen to the affected wounded area. The new product was 
tested for whether oxygen was still being produced once the batch was completed.   
7 
 
Authorship Page 
Section Name Section Name 
1 Introduction J. P. 3.7 Revised Client Statement J. P. 
2 Background and Literature Review J. P. 3.8 Management Approach A.N. 
2.1 Wound Healing A.N. 4 Design Process J. P. 
2.2 The Process of Wound Healing A.N. 4.1 Needs Analysis J. P. 
2.3 Chloroplast Functions J. P. 4.1.1 Pairwise Comparison J. P. 
2.4 Current Treatments and Research A.N. 4.1.2 Ranking the Requirements J. P. 
2.4.1 Wound Dressing (Hydrogel) J. P. 4.2 Conceptual Designs J. P. 
2.4.2 Hyperbaric Oxygen Therapy  J. P. 4.3 Alternative Designs J. P. 
2.4.3 Oxygen and Electrotherapy A.N. 4.3.1 Vaseline Infused Gel J. P. 
2.4.4 Vacuum-assisted Closure Therapy J. P. 4.3.2 Hand Sanitizer Gel J. P. 
2.5 Disadvantages of Current Treatments A.N. 4.3.3 Glycerol Hydrogel J. P. 
2.5.1 Hydrogel ALL 4.3.4 Band-aid infused with Gel J. P. 
2.5.2 HBOT J. P. 5 Design Verification J. P. 
2.5.3 Vacuum-assisted Closure Therapy  A.N. 5.1 Initial Preparing J. P. 
3 Project Strategy J. P. 5.2 Choosing the Material J. P. 
3.1 Initial Client Statement J. P. 5.2.1 Vaseline J. P. 
3.2 Objectives ALL 5.2.2 Hand Sanitizer J. P. 
3.2.1 Safety J. P. 5.2.3 Glycerol J. P. 
3.2.2 Delivery of Oxygen J. P. 5.3 Testing J. P. 
3.2.3 Consumers ALL 5.3.1 Hill Reaction J. P. 
3.2.4 Quality Control ALL 6 Final Design and Validation J. P. 
3.3 Functions A.N. 6.1 Final Design J. P. 
3.3.1 Produce Oxygen ALL 6.1.1 Isolating Chloroplast J. P. 
3.3.2 Ease of Use A.N. 6.1.2 Preparing the Solution J. P. 
3.3.3 Barrier A.N. 6.2 Impact Analysis J. P. 
3.3.4 Flexibility A.N. 6.2.1 Economics J. P. 
3.4 Standards J. P. 6.2.2 Environmental Impact J. P. 
3.4.1 Dermal Safety Testing J. P. 6.2.3 Societal Influence J. P. 
3.4.2 Hydrogels and Hyperbaric Oxygen 
Therapy 
A.N. 6.2.4 Political Ramification J. P. 
3.4.3 Labeling and Packaging J. P. 6.2.5 Ethical Concerns J. P. 
3.4.4 Quality J. P. 6.2.6 Health and Safety Issues J. P. 
3.4.5 Storage J. P. 6.2.7 Manufacturability J. P. 
3.5 Constraints A.N. 6.2.8 Sustainability J. P. 
3.5.1 Size of Applications A.N. 7 Discussion A.N. 
3.5.2 Cost A.N. 8 Conclusion A.N. 
3.5.3 Safety ALL 8.1 Future Work J. P. 
3.5.4 Comparisons to the Market A.N. 8.2 Recommendations A.N. 
3.6 Specifications A.N. 8.2.1 Disinfection and Sterilization J. P. 
3.6.1 Storage A.N.    
3.6.2 Resistance to Elements A.N.    
3.6.3 Oxygen Production A.N.    
  
8 
 
Table of Figures 
Figure 1-1 Steps of Wound Healing (Wijesinghe et al; 2014) ........................................................ 9 
Figure 4-1 Basic Concept Map ..................................................................................................... 38 
Figure 4-2 Detailed Concept Map ................................................................................................. 39 
Figure 5-1 Initial Preparation Materials ........................................................................................ 42 
Figure 5-2 Chloroplast Solution.................................................................................................... 43 
Figure 5-3 Chloroplast Solution with Vaseline ............................................................................ 44 
Figure 5-4 Chloroplast Solution with Heated Vaseline ................................................................ 44 
Figure 5-5 Chloroplasts with Hand Sanitizer................................................................................ 45 
Figure 5-6 Hill Reaction with Hand Sanitizer .............................................................................. 46 
Figure 5-7 Hill Reaction Under Ambient Light ............................................................................ 46 
Figure 5-8 Hill Reaction Under a Lamp: Left Initial at 0 minutes, Right After 7 minutes .......... 47 
Figure 6-1 Unit sales of Brand Names (Shahbandeh, 2019) ........................................................ 50 
Figure 6-2 Global Wound Care Market Share (Wound Care Size, 2019) .................................... 52 
Figure 8-1 Ranking the Bacteria Killed (CDC, 2016) .................................................................. 59 
  
9 
 
Chapter 1 Introduction 
The overall goal of this project was to design a new topical treatment, which will provide 
an addition of 5%-10% oxygen to the affected wounded area. This treatment will be safe for the 
patient to apply at the convenience of their home. This product will be able to be stored for at least 
six months. The topical treatment product will be consistent with the initial batch. This product 
will ensure a broad range of potential consumers. In the world there are about 6.5 million patients 
dealing with chronic wounds (Sen, et al; 2009). This has been an increasing problem for patients 
around the world. The number has been increasing due to the amount of health problems being 
increased such as diabetes, and obesity. These health problems make it harder for wounds to heal 
due to their underlying conditions.  
 
Figure 1-1 Steps of Wound Healing (Wijesinghe et al; 2014) 
There are four major steps which involve wound healing which are bleeding, inflammatory, 
proliferative, and remodeling. The first step is to stop the bleeding which is usually begun by the 
blood cells starting to clump together and clot. The next step, inflammatory is when one the wound 
is closed by the clot the blood vessels which allow nutrients and oxygen to enter. Blood-borne 
oxygen is needed for healing (DeMuro, Fraser & Foley). During proliferative the blood cells, 
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oxygen-rich blood cells will help build new tissue. The final stage remodeling is once the wound 
begins to regain strength and finally repair itself. The topical products which are currently in the 
market are mostly used for wound healing and taking care of a wound. As of now the only product 
being used for wound healing that incorporates oxygen is a hyperbaric oxygen chamber. This is a 
major reason for conducting these experiments, in order to help patients, heal their wounds at a 
faster pace.  
The following chapters in this report will discuss various factors leading to the final design 
of the product. They will also discuss how the product will have an impact on the global side of 
the market as well as on patients and people all around the world. The chapters will describe the 
clinical process of fabricating the oxygen producing hydrogel for wound healing, the project 
approach, and validating the design via different testing methods. The results from these tests 
described the correct ratio fabrication of the gel and chloroplast solution. Finally, the final design 
is analyzed based on the goals specified in the client statement. The team also provided 
recommendations and future works that can be considered.   
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Chapter 2 Background and Literature Review 
Background and literature research were conducted in order to familiarize with the scope of the 
project. Another reason was to understand the healing process of a wound and the effects of oxygen 
in them. The following sections give an overview of the process of wound healing, how 
chloroplasts functions and any current treatments being used.  
2.1: Wound Healing 
 When we sustain an injury such as a small cut or open wound, our bodies undergo a 
complex sequence of events to ensure that the wound is healed to the best of our abilities. Through 
the process of hemostasis, the blood cells start to clump together and clot which serves to both 
protect and close the wound area. Inflammation occurs where the blood vessels open to allow 
nutrients and oxygen into the wound for the healing process. Blood-borne oxygen is essential for 
healing. Inadequate blood supply, especially the lack of oxygen-rich blood, is one of the most 
crucial factors for interrupted wound healing. A wound not getting enough blood to deliver the 
essential nutrients and oxygen can take at least twice as long to heal properly. These are called 
chronic wounds that do not heal in an orderly set of stages. Wound healing can be taken for granted 
as it is the way our bodies attempt to revert to its original healthy state. 
 The start of the process begins with acute hypoxia and leads into oxygen recovery. Wound 
areas have a disrupted local vascular supply. The state of the wound also determines how effective 
the oxygen is when the wound is hypoxic, normoxia, or hyperoxia. Chronic hypoxia can impair 
the healing process as a result of not healing in an orderly set of stages. 
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2.2: The Process of Wound Healing 
 The basic steps of wound healing are hemostasis, inflammation, growth & rebuilding and 
strengthening. Within minutes or even seconds, the blood cells start to clump together and create 
a clot. This protects the wound from further blood loss as well as creating the first barrier to 
preventing wound infection before further care is applied. In inflammation, the blood vessels 
deliver nutrients and oxygen to the affected area in the process of healing. The levels of oxygen 
are important in this stage as too much or too little impairs efficient healing. As the repair process 
continues, blood cells arrive to build new tissue. In the process of granulation, tissue and 
microscopic blood vessels form on the surface of the wound by growing from the base and fills in. 
Collagen is created and serves as a scaffold for repairs to the area as more tissue fills in the wound. 
2.3: Chloroplast Functions 
Plants, as well as eukaryotic algae contain an organelle which helps them produce food. 
These organelles are known as chloroplasts, and they conduct this by a process known as 
photosynthesis. Photosynthesis is the process by which plants convert carbon dioxide and water 
into carbohydrates and oxygen by using the energy of the sun. Sunlight enters the chloroplasts, 
which then encounter the chlorophyll. There are different types of chlorophyll (a, b, c, d, and e) 
which each absorb energy from different wavelengths of the light. Chlorophyll a absorbs the 
energy from the violet-blue and reddish wavelengths. Once the chlorophyll traps the energy it will 
begin to split the water molecules into separate ions as well as free electrons. From these ions that 
were split the oxygen ion is released into the atmosphere while the hydrogen ion is carried to the 
stroma of the chloroplast. The remaining energy absorbed by the chlorophyll will be carried to the 
stroma, where the carbohydrates will be made. In the stroma it will combine the hydrogen ion, the 
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carbon dioxide which entered the leaf of the plants and it will be made into carbohydrates. Once 
this process is completed carbohydrates will be carried to the cells of the plant.  
2.4: Current Treatments & Research 
Today’s research and currently used methods of treating wounds are still expanding. 
Oxygen is a vital component in the process of wound healing but promoting higher levels of 
oxygen in the affected wound areas outside from the delivery of the necessary components from 
the blood vessels is the proof of principle that present-day research is still working on. Current 
known treatments today include a variety of applications and therapy which take advantage of 
adapting to work with the body. These methods are not only limited to providing 100% of pure 
oxygen but are also maintaining an optimum wound healing environment.  
2.4.1: Wound Dressing (Hydrogel) 
 Hydrogel dressings aids the body in protecting it from any infection and promotes efficient 
healing. The dressing provides a favorable healing environment by maintaining the wound warm 
and moist. This dressing is made up of about 90% water which is put on the gel. This gel is 
composed of hydrophilic polymers, which swell up they encounter water. The hydrogel provides 
moisture, which helps granulation, healing, as well as keeping the wound cool. This aids in 
alleviating the pain.  
Hydrogels are available in two types of forms: sheets or amorphous gels. From these two 
types of forms there are three types of hydrogel: hydrogel sheets, amorphous hydrogels and 
impregnated hydrogels. Hydrogel sheets are made of polymeric cross-linked molecules which are 
capable of absorbing water. The backing of the sheet aids in regulating evaporation from the sheet 
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and always keeps the wound moist. Amorphous hydrogels are gel like and can be applied freely 
onto the surface. The gel enters the crevices of the wound regardless of the depth of the wound. 
Usually, after applying the gel it may be covered with a gauze to it the gel in place. Impregnated 
hydrogels are gels applied to a gauze, sponge strip or pad, which then cover the wound and are 
further covered by a secondary dressing to seal the wound.  
2.4.2: Hyperbaric Oxygen Therapy (HBOT) 
 Hyperbaric oxygen therapy is a type of therapy which exposes the body to a 100% of pure 
oxygen. HBOT aids in many different forms, such as decompression sickness, serious infections, 
bubbles of air in the blood vessels and wounds that won’t heal. This therapy involves breathing in 
pure oxygen in a pressurized room or a chamber. Inside the chamber, the air pressure is increased 
three times higher than the normal pressure. Increasing the pressure increases the amount of 
oxygen you can breathe in. Once the oxygen is traveling throughout the body, it stimulates the 
release of growth factors and stem cells.    
2.4.3: Oxygen and Electrotherapy 
 There has been some research that demonstrates that if oxygen is administered, it can 
accelerate and sustain vessel growth. This phase is crucial in the start of wound healing as the local 
vessel blood supply must deliver the necessary materials to the affected area. Furthermore, there 
has been research conducted on the use of nanotechnology to create electrical pulses that induce 
mechanical displacements with body and muscle motions. This opens the path for more research 
to continue as it demonstrates the feasibility of electrical stimulations that are self-sustainable and 
biologically responsive. 
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2.4.4: Vacuum-assisted Closure Therapy (VAC) 
 Vacuum-assisted closure therapy (VAC) is a type of therapy in which it aids to heal 
wounds. A wound vacuum system has several parts. A foam or gauze dressing is put directly on 
the wound. An adhesive film covers and seals the dressing and wound. A drainage tube leads from 
under the adhesive film and connects to a portable vacuum pump. This pump removes air pressure 
over the wound. It may do this either constantly. Or it may do it in cycles. During the treatment, a 
device decreases air pressure on the wound. This can help the wound heal more quickly. 
2.5: Disadvantages of Current Treatments 
Despite current research development and methods of treatment used today, there still exist 
some disadvantages that make the application of oxygen in wound healing difficult. Primarily 
considering the method of application, current treatments still have room for improvement as the 
biological signals and functions of the human body must be considered in designing methods of 
treatment. 
2.5.1: Hydrogel 
 Even though a hydrogel has many advantages to it, there are some disadvantages that may 
prevent anyone from using it. A disadvantage would be that a hydrogel cannot absorb large 
amounts of liquids. This makes the hydrogel unsuitable for a wound that is secreting a lot of fluid. 
Furthermore, the trait of having low mechanical strength puts the durability of the application into 
consideration. If it tears, fluids spreading outside the wound area would be an inconvenience for 
the patient. 
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2.5.2: HBOT 
 Hyperbaric oxygen therapy is usually a safe procedure, but there are instances where some 
complications may occur. This treatment does carry some risks which may be both short-term and 
long-term. A short-term risk may be temporary myopia, which is caused by changes in the eye 
lenses. Due to increasing air pressure there are some risks associated with this. One of the risks is 
related to your ear, for example your eardrum may rupture as well as there can be leaking fluid. 
Another risk would be lung barotrauma which would cause the lung to be damaged or a lung 
collapsing. Due to the increase of oxygen there are also two major risks associated with this. One 
risk would be seizures which are caused by too much oxygen in the central nervous system. 
Another risk would be fire, which is due to the oxygen-rich atmosphere in the chamber.  
2.5.3: Vacuum-assisted Closure Therapy 
 The limitations of vacuum-assisted closure therapy are also plain in sight. Due to using a 
suction dressing, the device creates negative pressure on the wound. However, this machine also 
conducts noise and limits the patient’s mobility. The wound dressing consists of a sponge applied 
on top of the wound. During the healing process, the granulation tissue and nerve endings that 
regenerate can grow into the sponge material. The process of removing and redressing the wound 
can induce little to significant pain as a result of removing the sponge. 
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Chapter 3 Project Strategy 
In this chapter the initial client statement was discussed. The objectives of the project were 
discussed as well as goals, functions, and standards. There are also different types of test that may 
be performed in order to determine the quality of the product. In this chapter the different 
competitions that are out there are also explained. 
3.1 Initial Client Statement 
 At the beginning of the project, the client and the team generated an initial client statement 
based on the main goal of this product. The main goal is to produce any topical product that will 
be able to give off oxygen to help the wound heal. 
“Design a topical treatment to provide increased oxygen to the 
surface of an open wound.” 
This initial statement has been improved by stating the goals or objectives that the product will 
need to comply with. Some the objectives that will be incorporated in this statement are listed in 
list #1 (section 3.2). 
3.2 Objectives 
 Identification of the objectives was the initial step in determining the roadmap for the 
technical aspect of the final design. An objective is a goal or when someone aims to achieve a 
desired result. These objectives are listed below in list #1. The team determined these objectives 
based on the client’s needs or wants. Another way of finalizing the objective list was by using 
Information from the research conducted for chapter 2. It has helped decrease the long list of 
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objectives and categorize them into these specific 5 objectives. The final design should be safe for 
the consumers to use, deliver oxygen, provide a range of potential consumers, and ensure quality 
control. 
1. Safety 
2. Delivery of Oxygen 
3. Consumers 
4. Quality Control 
List #1: Main topics for objectives 
3.2.1 Safety 
Safety has been one of the major objectives that needs to be complied with for this project. The 
federal government also has three agencies who are responsible for ensuring consumer safety. 
These three agencies are the Food and Drug Administration (FDA), the Consumer Product Safety 
Commission (CPSC) and the Environmental Protection Agency (EPA) (Why is Product Safety 
Needed). Some of the toxicity or characteristics that classify a product unsafe for a consumer to 
use may include but are not limited to products that cause any irritation, inflammation, or further 
infection to the affected wounded area (Grimes & Lyssikatos, 2018). The wound dressing should 
be safe for the user, complying with FDA, ISO, and ASTM standards and regulations. Some of the 
characteristics that we may consider for this product is for it to not cause any irritation, rash or any 
infection to the wounded area. 
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3.2.2 Delivery of Oxygen 
The delivery of oxygen is an important objective for this product since oxygen is the main 
“ingredient” involved in the composition of the topical product. Oxygen will be delivered to the 
affected wounded area through a type of hydrogel. The consumer will apply this gel which will be 
delivering oxygen for a certain amount of time period. Oxygen will need to be delivered at an ideal 
oxygen level over the duration of the application (5% to 10%.)  
3.2.3 Consumers 
The wants of the consumers and what they are looking for in a product is also an important 
objective. This is because their opinion matters, since they are the potential candidates for this 
drug. If the consumers do not like the idea of having oxygen being administered in a topical product 
or applying a foreign product to their body can be hard to convince them to buy and try the product. 
The product will not need to be odorless, due to the fact that if the product creates a certain type 
of odor on their body, they will restrain themselves from using the product. As stated before, the 
product will need to be safe for consumers of all types of skin. If it is safe on sensitive skin, it will 
limit the irritation or rashes that it can create.  
3.2.4 Quality Control 
The quality of the final product is important because it needs to ensure the same consistent quality 
and results from batch to batch. The quality of the finished product is not only based on the function 
or performance, but it is also based on the appearance and the quality of the ingredients that make 
up the product (Ueda, 2010). A visual examination that is performed on the product should identify 
if there are any changes in color, viscosity, or any separation of the ingredients (Ueda, 2010).  
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3.3 Functions 
The functions of the design serve to meet the design requirements. The list below (list #2) shows 
the four major functions that the product must comply with. The wound dressing should be self-
sufficient, requiring no external attachments or professional help in applying, a barrier for the 
product, as well as how flexible it will be with the barrier. 
1. Produce Oxygen 
2. Ease of Use 
3. Barrier 
4. Flexibility 
List #2: Main topics for functions 
3.3.1 Produce Oxygen 
The primarily function for the purpose of this design is the production of oxygen. Oxygen is a 
major component for this product since oxygen is a key factor in the wound healing time. Oxygen 
is meant to decrease the average time it takes for a wound to heal. Oxygen is a requirement for 
various processes in the healing of wounds including collagen deposition, epithelization, 
fibroplasia, and angiogenesis (Castilla, Liu, & Velazquez, 2012). A few other functions of oxygen 
are also to kill bacteria and reduce infections (Castilla, Liu, & Velazquez, 2012). Oxygen 
stimulates the creation of new blood vessels and aids growth factors to form new skin (Castilla, 
Liu, & Velazquez, 2012). The design will incorporate a method of maintaining a desired level of 
oxygen in the wound area. 
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3.3.2 Ease of Use 
Since the consumers will be using this product it needs to be the simplest form of application. The 
product will be easy to use at the convenience of their house. This product will not need any 
medical intervention or seek any medic to apply this product for them. It should be designed so 
that the user could apply the product and cover the wound without additional assistance from 
machines or professional help. This product will also not require any knowledge of how to use any 
devices or technological materials.  
3.3.3 Barrier 
Another function that is crucial to promoting a proper wound healing process is preventing 
infections. The design should function as a barrier on application, separating the wound area from 
the environmental surroundings so that its primary function of oxygen production and delivery to 
the wound may be uninterrupted. 
3.3.4 Flexibility  
Its flexibility should aim to adapt to the user’s skin and adhere properly, an additional consideration 
to keep in mind for the barrier. 
3.4 Standards 
Standard for a product are ideas which are designated to be used as guideline or rules. Standards 
are chosen by what the new product will be composed of. Since this product will be a topical 
product, the standards that must be followed are standards for the skin, as well as pharmaceutical 
standards. Some of the few standards that must be followed are listed below (list #3) It should also 
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be able to compete with the standards set by current products on the market such as durability, 
ease of use, and water resistance.  Some of the current products in the market which are like the 
product being spoken of are hydrogels and Hyperbaric Oxygen Therapy (HBOT). The most similar 
product is Hyperbaric Oxygen Therapy since it uses the major component that is being used, 
oxygen.  
1. Dermal Safety Testing 
2. Hydrogels and Hyperbaric Oxygen Therapy 
3. Labeling and Packaging 
4. Quality 
5. Storage 
List #3: Main topics for functions 
3.4.1 Dermal Safety Testing 
Dermal safety testing must be done in order to assess the risk of the investigational drug. The tests 
will assess the tolerance of the drug under exaggerated conditions. Materials that are to be in 
contact with the skin should not cause any damage to the area it will be applied to or cause any 
irritation. The topical device must be biocompatible to skin, as well as the wound tissues it will be 
applied to. According to the ISO10993-1, “Biological evaluation of medical devices - Part 1: 
Evaluation and testing within a risk management process,” it states that the product must be also 
tested in the final condition that it will be used (FDA, 2016). There are tests that need to be 
completed in order to determine the safeness of the product, as well as if it is biocompatible with 
humans. The first test that may be conducted is cytotoxicity, which is the extent to which the 
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material will possess a specific destructive action of the cells being used. When conducting the 
cytotoxicity test there are three characteristics used to determine the method that will be used: 
extract, direct contact, indirect contact. One type of cell that may be used are mammalian cells, 
and they can be incubated for a certain time period. After the incubation period is complete the 
cytotoxic effect is evaluated based on the table below (table #1).  
Table 1 Qualitative Morphological Grading of Cytotoxicity of Extracts 
Grade Reactivity Conditions of all Cultures 
0 None Discrete intracytoplasmic granules, no cell lysis, no reduction of cell 
growth 
1 Slight Not more than 20 % of the cells are round, loosely attached and without 
intracytoplasmic granules, or show changes in morphology; occasional 
lysed cells are present; only slight growth inhibition observable.  
2 Mild Not more than 50 % of the cells are round, devoid of intracytoplasmic 
granules, no extensive cell lysis; not more than 50 % growth inhibition 
observable.  
3 Moderate Not more than 70 % of the cell layers contain rounded cells or are lysed; 
cell layers not destroyed, but more than 50 % growth inhibition 
observable.  
4 Severe Nearly complete or complete destruction of the cell layers.  
ISO 10993-10 part 10: “Tests for irritation and skin sensitization,” states the procedures and the 
limitations for irritation on the skin. This will determine the probability that the product will cause 
irritation to humans when they are using it. The site chosen for the test exposure would be to use 
the most appropriate and sensitive for the indicated use. For the product being explained here, the 
site to use would be the skin. Other sites would include the eye or mucosal membrane. Once these 
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tests have been conducted, they are evaluated and rated on the scores being shown in table #2. 
Different mean scores derived from the table #2 has its own response category. A mean score of 0 
to 0,4 will be considered negligible. A score from 0,5 to 1,9 it will be considered slight irritable. 
A mean score of 2 to 4,9 will be considered moderate. Finally, a score of 5 to 8 will be considered 
sever.  
Table 2 Scoring System for Skin Reaction 
Reaction Score 
Erythema and eschar formation  
No erythema  0 
Very slight erythema (barely perceptible)  1 
Well-defined erythema  2 
Moderate erythema  3 
Severe erythema (beet-redness) to eschar formation preventing grading of erythema  4 
Oedema Formation  
No oedema 0 
Very slight oedema (barely perceptible)  1 
Well-defined oedema (edges of area well-defined by definite raising)  2 
Moderate oedema (raised approximately 1 mm)  3 
Severe oedema (raised more than 1 mm and extending beyond exposure area)  4 
Maximal possible score for irritation 8 
ISO 10993-10 part 10: “Tests for irritation and skin sensitization,” states the procedures and the 
limitations for another type of testing is sensitization. The sensitization test will test the potential 
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of a material or product to cause a sensitizing effect or allergic reaction in a patient over an 
extended period of exposure. This test is used when the product will come in direct contact with 
the skin, and the duration of the tests will last for a period of 5 weeks. Once the five weeks, have 
passed the results are given a grading scale based on the notable appearance of the affected area. 
There are two tests associated with this type of standard: The Guinea Pig Maximization Test 
(GPMT) and the Closed Patch Test. GPMT. The maximization test is the most sensitive and will 
produce the most accurate results. Extracts using 0.9% saline and cottonseed oil are prepared from 
the product. The test is performed in a series of three stages extending over a period of 4 weeks. 
The closed patch test is used mostly for materials that will have direct skin contact. It is performed 
in a series of phases over a period of 5 weeks. 
Table 3 Magnusson and Kligman scale 
Patch test reaction Grading scale 
No visible change 0 
Discrete or patchy erythema 1 
Moderate and confluent erythema 2 
Intense erythema and/or swelling 3 
3.4.2 Hydrogels and Hyperbaric Oxygen Therapy 
Current treatments available that are related to this project are hydrogels and hyperbaric oxygen 
therapy (HBOT). HBOT is a chamber in which the air pressure is increased higher than the normal 
air pressure. Once the air pressure is increased, the lungs will be able to gather more oxygen than 
what they are capable of breathing (Mayo Clinic, 2018). In 21 CFR 878.4022 it states a few 
regulations that the hydrogels must follow. These regulations are that hydrogel wound dressing 
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may not contain any additional drugs: antimicrobial agents, growth factors, or material derived 
from animals. The hydrogel must be composed of hydrophilic polymers or other material in 
combination with water. The range that the composition of the hydrogel must be is based on the 
percentage of water, which must be of at least 50 percent (FDA, 1999). There are a few functions 
that this hydrogel must be able to perform: absorb wound discharge, control bleeding, control fluid 
loss, and to protect against anything rubbing against it. For the HBOT there are many more 
different requirements that must be followed since this involves a step-by-step procedure to be 
performed. One of the major requirements is that medical directors must meet all the qualifications 
required. The Food and Drug Administration (FDA) has cleared hyperbaric chambers for certain 
medical uses, such as treating decompression sickness suffered by divers. During the procedure 
the minimum number of team size is of two people: the hyperbaric physician, the operator.  
3.4.3 Labeling and Packaging 
The labeling regulations are different for over the counter drugs compared to prescription drugs. 
For labeling and packaging there must be written up documents that depict the steps that need to 
be followed to ensure the correct labels and packaging materials. They each have their own 
separate regulations and requirements that need to be followed. In the document 21CFR211 section 
211.125 Labeling issuance, it depicts the strict control there is on the labels being issues for the 
use in the drug products. The batch that is set to be labeled should be carefully examined and 
identify if it conforms to the labeling specified in the master production records. Once there is a 
discrepancy found the entire batch will need to be investigated according to 211.192. Another 
standard that is stated is that once there is an excess amount of labeling or control numbers must 
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be destroyed and not put away. If a label has been returned, they should be classified and stored 
elsewhere. This will avoid any mix-up with the new labeling being used (FDA, 1995).  
3.4.4 Quality 
Thus, product quality may be assessed in terms of quality of the physical chemistry make-up of 
the finished product and the physical performance of the finished product. Product quality testing 
separated into two separate groups of tests: product quality tests and product performance tests. 
Three Test Categories for Semisolids: Universal Tests, Specific Tests (as appropriate/applicable) 
and Specific Tests for Topical Semisolid Products 
According to 21 CFR 320.1 it states that there are two requirements that need to be followed which 
are bioavailability and bioequivalence. Bioavailability is the rate at which the active ingredient is 
absorbed from the product and becomes available to the site of action. For the products which are 
not intended to be absorbed by the bloodstream also need their bioavailability to be evaluated. This 
can be measured by the rate at which the active ingredient is available at the site. The 
bioequivalence requirement is mainly by FDA which involves two testing methods (in-vivo and 
in-vitro testing) of the product which must satisfy the condition that it is intended for the 
patients.  Another requirement is the same drug product formulation. This means that the product 
being provided must have a constant composition from the definition formula submitted for 
approval. There may be some differences, but it must be similar enough to the bioequivalence 
provided. 
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3.4.5 Storage 
 There are also different standards, requirements, and testing that need to be followed to 
assess the stability of the product. The stability will include determining the expiration date as well 
as what the desired storage conditions are. In 21CFR211: “Current Good Manufacturing Practice 
for Finished Pharmaceuticals” it states that there should be a written document discussing the 
standards and the conditions that need to be followed. The written document shall be followed and 
shall include the results of the testing that has been conducted. These shall include but are not 
limited to the sample size used, the storage conditions determined, and the test methods performed 
(FDA, 2016). Some standards of the testing that must be followed is that the drug product will be 
tested in the same closed system that the drug will be used in the market. The testing will be 
conducted by reading and using it as directed in the label. Enough batches for the drug product 
must be tested to determine the appropriate expiration date and a record of such data shall be 
maintained (FDA, 2016). In order to determine the expiration date there must be different drug 
product testing conducted at different intervals. 
3.5 Constraints 
There are a few constraints that limit the objective of the design, as well as that the team must 
consider through this design process. The overall meaning of a constraint is something that will 
impose a restriction or prevent this product from being fabricated. These constraints are listed 
below: 
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1. Size of Application 
2. Cost 
3. Safety 
4. Comparisons to the Market 
List #4: Main topics for constraints 
3.5.1 Size of Application 
The size of the application will be a constraint due to the fact that it will need to be able to cover 
an area of at least 2cm by 2 cm. The safety of the consumer is also a constraint for the project in 
which we need to take every risk that can occur into consideration. The product must be 
biocompatible with the skin, in which there must not be any cytotoxic materials or compound. 
3.5.2 Cost 
 Cost and financial availability is a constraint due to the fact that the product will need to 
go through various amount of testing. There is limited amount of materials being provided and 
limited amount of money provided. The amount of spending amount available is $500 for the entire 
team. There are machines or devices that would help this project in obtaining better results as well 
as obtaining more information that would help justify that this product works. Another constraint 
will be that if there are expensive materials or the cost of production is high, this will not create a 
cost-efficient price for the consumers. 
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3.5.3 Safety 
 Safety is a concern for this product because of the ingredients that are going to be used. 
Most of the safety testing will not be able to be performed or accessed, due to the time-constraints 
of the project.  
3.5.4 Comparisons to the Market 
Furthermore, there isn’t any product or device on the market currently that achieves our objectives. 
The product needs to be safe for the consumers to use, deliver oxygen, provide a range of potential 
consumers, and ensure quality control. As such, we do not have any similar products to refer to for 
analyzing the standards and specifications given. The standards and specifications we are trying 
to achieve are determined by ourselves in the design process within limitations given the time and 
resources we have. Our team still aims to analyze many wound dressing and application products 
that are relevant to our design objectives. Understanding the constraints of similar products will 
allow us to better determine what is feasible and what should be prioritized in the design like cost 
of production and manufacturing capabilities. There is not enough demand in the market to match 
the supply of your product. There is not enough supply of your product to match the demand in 
the market. 
3.6 Specifications  
The specifications listed below were derived from the function that the design will need to satisfy. 
A specification is a detailed description of the design and materials that will be needed to make 
the product function.  
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1. Storage 
2. Resistance to elements 
3. Oxygen Production 
List #5: Main topics for specifications 
3.6.1 Storage 
As such, the product should also have a long shelf life and easy storage for the convenience of the 
consumer. The shell-life for the topical product being used will be of at least 18 months in order 
to potentially compete in the market versus similar products. Some of the similar products have 
been discussed before which are hydrogels being used for wounded areas. The shelf-life has been 
determined due to the fact that the shelf-life of a hydrogel has been determined to be 18 months 
under ambient conditions (Bates & Magda, 2014).    
3.6.2 Resistance to Elements 
The amount of sunlight the product will need to be exposed to is at most 45% of the sunlight. Our 
team plans to do a multitude of stress tests to determine what material is best for the composition 
of the design, considering how much should the product be able to handle. We will be testing for 
mechanical strength, shear stress, strain, flexibility, etc. The material should be able to contain the 
necessary substances like a gel for holding the chloroplasts while safety adhering to the user’s 
skin. Tensile strength and flat plate water trials are the types of tests we plan to conduct for material 
choices and measure the specifications needed for the design. 
 
32 
 
3.6.3 Oxygen Production 
One measurement to take note of is how much oxygen can be produced over a certain volume or 
surface area. One of our objectives is to ensure that the product is easy to apply for the consumer 
without the need for professional help.  
3.7 Revised Client Statement  
 After adjusting the objectives based on the client’s needs as well as through research 
conducted from current literature, the client statement was able to be revised. The client statement 
now reflects the overall goal of the project, as well as the main objectives that this product needs 
to produce. The revised client statement is: 
“Design a new topical treatment, which will produce oxygen for 24 hours 
to the affected wounded area. This treatment will be safe for the patient to 
apply at the convenience of their home. The product will be able to be 
stored for at least six months. The topical treatment product will be 
consistent with and ensure a broad range of potential consumers.” 
3.8 Management Approach  
 In identifying different stakeholders in our project, clarifying objectives, and considering 
our constraints, the preliminary design will be developed for a prototype and testing. Even though 
no marketed products offer the capabilities sought by our client, comparison charts and analysis 
can still be conducted to determine the competition and global standards for wound dressings and 
33 
 
similar products. The characteristics of our final design will determine if we follow the regulations 
established for medical devices or pharmaceutical methods.  
 In the prototyping phase, the logistics will be considered for making material choices for 
testing and implementing with the inclusion of chloroplasts for oxygen production. This phase will 
be crucial for evaluating our limitations and any issues with the design from a conceptual 
standpoint and a development standpoint. Following up on the testing phase is meeting the 
regulatory standards to potentially put this product out on the market. Financial aspects such as 
cost-effectiveness in production and monitoring in quality control are future considerations. 
 Below is an outline of a Gantt Chart (first half of the project year) subjected to change as 
we work through the phases of the project. Workarounds will be expected depending on any 
unexpected setbacks as we aim to narrow down our scope to focus on the primary objectives of 
the project. 
The time available for the project is a major constraint in that we need to have everything 
completed and ready to submit by April. This gives us about 6 months to complete the production, 
the testing and if something were to fail during the testing, we would need to perform further 
alterations. The time available for the product to be produced is also limited since we have until 
April to submit our results, this means that we need at most two months prior to this for testing. 
Taking this into consideration, the product will need to produced and ready for testing by January. 
The team also shares a budget of 500 USD during the project design. This budget entails for any 
traveling to conduct research or any potential interviews, as well as using it to construct and test 
the prototype.   
34 
 
Chapter 4 Design Process 
Here it is discussed the process of determining the final design process. The objectives, goals and 
functions were all weighed out and determine the importance of each one. The basic concept map 
is depicted here as well as the detailed concept map. The three different experiments are also 
discussed. 
4. 1 Needs Analysis 
After ranking the design objectives and developing the client statement, the design team began to 
organize a list of functions for the scaffold that would satisfy the desired objectives. The team 
began by drawing from the literature review to brainstorm an initial list of functions and design 
specifications. Brainstorming with the client was used to inspire means and approaches to the 
conception of the scaffold. Afterwards, a preliminary function and means list was generated and 
eventually pruned to better fit the client objectives. 
4.1.1 Pairwise Comparison 
The team ranked the objectives described in chapter 3 using a pairwise comparison chart, as shown 
below in Table 4. A pairwise comparison chart will determine the importance of the design 
objectives by listing the objectives across the first row and down the first column of a table. Then 
the objective in the column is compared against the objective in the top row. When there is a 
number 1 in either box this means that the objective in the column is more important than the 
objective listed in the row. When there is a number zero this will be the opposite, the objective in 
the column will be less important than the objective in the row. Once the boxes are all filled up, a 
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total number is achieved from adding across the table. This will indicate the weight of each 
objective. For table #4, the most important objective was found to the least important: safety, 
delivery of oxygen, quality control and consumers. This process was repeated for the goals, as 
well, which can be seen in table #5. The order of importance for the goals was ranging from 
production of oxygen, ease of use, barrier and finally the least important is flexibility.  
Table 4 Objectives 
 Safety Delivery of Oxygen Consumers Quality control Total 
Safety x 1 1 1 3 
Delivery of Oxygen 0 x 1 1 2 
Consumers 0 0 x 0 0 
Quality control 0 0 1 x 1 
Table 5 Goals 
 Produce Oxygen Ease of use Barrier Flexibility Total 
Produce Oxygen x 1 1 1 3 
Ease of use 0 x 1 1 2 
Barrier 0 0 x 1 1 
Flexibility 0 0 0 x 0 
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4.1.2 Ranking the Requirements 
Table 6 Requirements 
Requirements Team Client Total 
Safe for the patient to apply to their skin 5   
It will meet the client’s needs and or wants 4   
There will be oxygen flow 5   
It will ensure a range of potential consumers 2   
The quality control will be kept the same 4   
It will produce oxygen 5   
It will be able to be applied by the consumer (no medical intervention) 3   
It will need a barrier or covering after each application 3   
The covering or barrier will be flexible 1   
The product will be cost-effective 2   
Storage for an extended period (6 months) 1   
5 (Must Have) 
The final product must be able to produce oxygen for a set amount of time. As well as have constant 
oxygen flow on the affected wound area. This produce must be safe for any patient or consumer 
to use and will not create any reaction to the product. 
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4 (Important) 
The second goal is to meet the client’s needs or wants without affecting the consumers well-being. 
The second goal is for the batch created to have a consistent amount of oxygen production. There 
will not be any major fluctuations of oxygen being produced.  
3 (Good to Have) 
By creating this product, it will be able to be applied by the consumer himself. This will not need 
any medical intervention, or any external technology or devices used. The hydrogel that is selected 
for use within the system 
could be used with an external covering to avoid any further contamination of the area. 
2 (Not Needed, but Would Be Nice to Have) 
An additional goal is to provide a low cost and cost-efficient for low income class consumers. This 
will also ensure a broader range of consumers. Ensuring a broader range of consumer can increase 
the sale of the product and the viability of it.  
1 (Not Necessary) 
The last goal is that if a covering is being used it will not produce any discomfort for the consumer. 
The barrier will be un-noticeable as well as easy to apply on top of the product. The storage time 
for the product would be great if it can be stored for at least six-month in its container without its 
function degrading.  
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4.2 Conceptual Designs 
After determining the priority of the objectives, design constraints, goals, requirements and 
functions, a conceptual design was brainstormed. This basic conceptual design is shown in figure 
1, which begins of with the main purpose of the product divided into three subsections. There were 
three main components listed for the product which are the hydrogel, oxygen, and the topical 
application.  
 
Figure 4-1 Basic Concept Map 
Even though the basic concept map in the figure above shows the fundamentals of the product, a 
more in-depth concept map was created as well, shown below in figure 2. This concept map is 
beginning with the main purpose of the product divided into the three main subsection: topical 
application, topical products, and oxygen producing. These three subsections will then be divided 
further into their own different sections which will help understand the product more in-depth. For 
the topical product, it was divided into the types of products that may be used. For the oxygen 
producing section it was divide into the light source needed as well as the mechanisms to measure 
the release of oxygen.  
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Figure 4-2 Detailed Concept Map 
4.3 Alternative Designs:  
At this point of the design process it is known the preferred design that would be best for this 
product. Therefore, we considered four alternative designs that would represent and follow the 
guidelines of out project. These alternative designs will satisfy the goals, objectives, and 
requirements that were set by the client statement. These designs will be used as backup design 
just in case the preferred design fails at some point or it is not producing the desired results. The 
designs will also comply with the concept map and can be used as future design and improvements 
for the product 
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4.3.1 Vaseline infused gel 
This was the initial design chosen to use as the mixing agent with the chloroplast solution. The 
Vaseline was going to be used as its solid form, but it was also heated in order to dissolve it to 
properly mix it with the solution.  
4.3.2 Hand sanitizer gel  
Hand sanitizer was the second option to use as the mixing agent with the chloroplast solution. The 
hand sanitizer was not manipulated but used as it was from the bottle. This may not properly work 
due to the hand sanitizer having alcohol. Alcohol will kill the chloroplast cells and not make them 
viable in the solution. 
4.3.3 Glycerol Hydrogel 
Glycerol is the third back-up just in case the other two substances have not properly worked. 
Glycerol is an ingredient that is used in burn ointments. People are familiar with using this on their 
burn wounds as well as it does not contain any ingredient harmful to the chloroplasts. 
4.3.4 Band-aid infused with a layer of gel 
A band-aid infused chloroplast solution would have been great in creating. Due to limited time 
and materials this was not possible. The band-aid would have to be manipulated in order to allow 
any source of light to enter for the chloroplasts. The band-aids also have size limits while creams, 
ointments, and gels do not. They can be applied to any place and any size of area.  
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4.4. Final Design Selection:  
Table 7 Comparing Alternative Designs 
 Time Availability Compatibility Total 
Vaseline 4 4 1 9 
Hand-Sanitizer 5 5 3 13 
Glycerol 5 5 5 15 
Band-aid 3 3 5 11 
As you can see in the table above, when comparing all the alternative designs there was only one 
design which stood out the most. Even though that design stood out, there were tests performed 
for Vaseline and Hand-Sanitizer in order to completely rule them out. Upon different types of 
testing Vaseline was the first to be ruled out. This was most due to the fact that it would not 
properly mix with the chloroplast solution. The second to be ruled out was hand sanitizer, this was 
due to the alcohol content that it has. Band-aid was also ruled out at the initial brainstorming 
because of the many changes that may have to be done to the band aid itself. Another change was 
how the gel was going to be incorporated in the band-aid without it seeping out and changing the 
integrity of the adhesive.  
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Chapter 5 Design Verification  
In this section the process of performing the experiments are explained. It is also explained how 
the final design was obtained and why the desired measurements were used for each product used.  
5.1 Initial Preparing 
In order to begin with the preparation there was a need to verify the amount of each material 
needed. The batch for the final design was created by mixing five grams of spinach leaves with a 
solution that contained P0.5 M Sucrose x 1 Phosphate-Buffer Saline (PBS), filtering it and 
spinning the tube in the centrifuge. This isolated the chloroplasts and created a final batch 
containing 25 ml of solution. 
 
Figure 5-1 Initial Preparation Materials 
The batch for the final design was created by mixing five grams of spinach leaves with Phosphate-
Buffer Saline (PBS), filtering it and spinning the tube in the centrifuge. This was spun at 2,000 
rpm for 10 minutes. This isolated the chloroplasts and created a final batch containing 25 ml of 
final solution. 
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Figure 5-2 Chloroplast Solution 
5.2 Choosing the Material 
In order to determine which product is compatible with the chloroplast solution there was one 
experiment performed. The hill reaction was performed to determine whether the product and the 
chloroplast solution are compatible with each other 
5.2.1 Vaseline 
The initial batch was going to be tested with Vaseline. Vaseline is also known as petroleum jelly, 
and it is a hydrophobic molecule. Since it is a hydrophobic molecule it will repel the water. As 
shown in the figure below the Vaseline and chloroplast solution does not mix well together.  
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Figure 5-3 Chloroplast Solution with Vaseline 
Due to this we decided to heat the Vaseline to determine whether in a more liquified state it will 
accept water. The Vaseline was heated in warm water, but when it was combined with water it did 
not mix well either, the results are shown below. 
 
Figure 5-4 Chloroplast Solution with Heated Vaseline 
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5.2.2 Hand Sanitizer 
Once Vaseline was not a good compatible with the chloroplast solution, the team moved on to 
using hand sanitizer. Hand sanitizer was compatible with water in which they bonded perfectly 
together. The alcohol breaks down the chlorophyll, taking the green color out of the leaf. After a 
day or two the alcohol will begin to kill the chloroplast.  
 
Figure 5-5 Chloroplasts with Hand Sanitizer 
5.2.3 Glycerol 
The next option after trying to use Vaseline and hand sanitizer was incorporating glycerol. 
Glycerol is one of the main ingredients used in wound ointments that are for burn victims. Glycerol 
is a colorless, odorless, and very viscous liquid that is contained in a clear bottle. Glycerol is a 
non-toxic substance which is not harmful to the human skin. Glycerol has antimicrobial, antiviral 
properties and is widely used in wound and burn treatments. 
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5.3 Testing 
There were two types of testing done for this final product in which it helped us better observe 
whether the chloroplasts were still producing oxygen after a certain amount of time. These testing 
were to determine whether our chosen material, glycerol, will be compatible with the chloroplast 
solution.  
5.3.1 Hill Reaction  
 
Figure 5-6 Hill Reaction with Hand Sanitizer 
The first test was using the hill-reaction without using any light source, instead we just used the 
light which was around us. Without using any light source did produce oxygen, but it took longer 
for the hill-reaction to occur. 
 
Figure 5-7 Hill Reaction Under Ambient Light 
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The following test was using the same amount of chloroplast solution while using a lamp as a light 
source. The changes are shown below in figure 6 which it took a less time for the hill-reaction to 
take place. The left image depicts the glycerol and chloroplasts at zero minutes while the right 
picture depicts it after 7 minutes of testing. 
 
Figure 5-8 Hill Reaction Under a Lamp: Left Initial at 0 minutes, Right After 7 minutes 
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Chapter 6 Final Design and Validation 
The team analyzed the composition of the final design and determined what the steps of producing 
this product was. The team also analyzed the impact of this product on the environment as well as 
how it would change the countries. The team considered how the new hydrogel producing oxygen 
would perform on the economy, environment, society, politics, ethics, health and safety issues, 
manufacturability and sustainability. This product will have both positive and negative impacts on 
these issues. 
6.1 Final Design 
After performing these different types of experiments. There was one weight of the spinach leaves 
which was enough to function properly with the chloroplast solution. These steps and materials 
are explained in the following subsections.  
6.1.1 Isolating Chloroplasts 
The spinach leaves will be weighed out to measure around five grams using the scale. Once the 
leaves have been weighed out, they will be crushed in the mortar with the pestle. This will be done 
until tee laves are fully crushed. Once the leaves have been fully crushed, there will be 25 ml of 
PBS added into the mortar. The leaves will be crushed some more. Here you will begin to notice 
the PBS will begin to turn a slight green color. Once this has been properly crushed and mixed it 
will be filtered using a coffee filter into a centrifuge tube. The coffee filter will be inserted into a 
funnel to make the process easier in pouring. The solution will fill up the centrifuge tube and it 
will be spun at 2000 rpm for 10 minutes. After 10 minutes you will have noticed that there was 
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still some dead cell wall and other foreign substances that passed through the coffee filter. You 
will aspirate the solution into a new centrifuge tube without aspirating any substance that has 
settled on the bottom of the tube. You will take 7 microliters of solution and use a hemocytometer 
to analyze whether there are chloroplasts present in the solution.  
6.1.2 Preparing the Solution 
Once it was confirmed that there were still viable chloroplasts present in the solution now the 
solution will be prepared. This is the final part of preparing the hydrogel. The solution will be a 
one to one ratio of glycerol and the chloroplast solution. Since grams and milliliters are 
proportional to each other in that 0.5 grams will equal 0.5 milliliters. So, when weighing out the 
glycerol the boats were used, and the balance was zeroed every time a new measurement with a 
new boat was used. The glycerol was added slowly into the weigh boats to enable proper 
measuring. The chloroplast solution was measured by using the micropipette tools.  
6.2 Impact Analysis 
There are many different factors which come in play when creating a new product. These steps 
both have positive and negative impact on the product, economy, society, and environment. There 
are also many ethical problems which come into play when there are tests performed with these 
new products.  
6.2.1 Economics  
There are varying materials for different types of wounds. For example, for burns there are 
hydrogels and ointments that both are to help relieve the pain and heal. As you can see in figure 
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10, in 2019 the United States sold about 42.1 million first aid tape/ bandages (Shahbandeh, 2019). 
Since health care costs have been increasing throughout the years, in 2009 about 25 billion dollars 
was spent on treating chronic wounds (Sen et al., 2009). The cost of a standard dressing would 
cost around 24 dollars, when the dressing is changed every other day. So, for a six-month period 
of using a dressing it would cost about 3,500 dollars. This cost is without the use of any dressing 
or ointment. If there was a dressing used it would cost about 30 dollars a use, resulting in about 
1,000 dollars in three months (Al-Gharibi, Sharstha, & Al-Faras, 2019).  
 
Figure 6-1 Unit sales of Brand Names (Shahbandeh, 2019) 
6.2.2 Environmental Impact  
There are many positive effects of having this naturally made hydrogel. As we all know planting 
trees have a great impact on the environment as do planting small plants. Once a spinach plant is 
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plants it will begin to improve the quality of the air as well as the humidity levels. Plants as well 
as trees also aid in noise pollution, in that they absorb the noise around them. When there is a 
significant amount of pollutants plants will absorb these and convert it to food. Plants absorb the 
pollutants from the air through their stomata. Once the pollutant is transported to the root it will 
biodegrade the pollutants into structure which they will use as food (Benefits of Plants). 
6.2.3 Societal Influence  
This new oxygen producing hydrogel will have a great impact on society. Currently in the market 
there are no hydrogels which produce oxygen. The only oxygen producing device in the market is 
the Hyperbaric Oxygen Chamber. There are many disadvantages with this device in that the 
patients must go into the medical office to get the treatment. The cost of these treatments would 
range from thousands of dollars and there would be many sessions in order for a wound to fully 
heal. In using a hydrogel, it will provide less scarring than using other ointments. This is especially 
important in cases of burn victims. Their trauma of being burnt and how they will look with all 
their scars will increase high depending on the severity of the wound.  
6.2.4 Political Ramifications 
Since the United State and some other major countries are the leading countries in producing 
topical wound care it will benefit these countries the most. As you can see in figure 12 hospitals 
are the largest share which uses wound care products followed by clinics, home healthcare and 
finally others.  
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Figure 6-2 Global Wound Care Market Share (Wound Care Size, 2019) 
6.2.5 Ethical Concerns  
There are some ethical concerns involved with this new hydrogel that was created. The main 
concern that may be available is the amount of testing that needs to be done on animals. Improper 
animal care and the protocol that must be followed to test the product on the animal will concern 
many people. The protocol will need to be followed according to the Institutional Animal Care 
and Use Committees standards (IACUC). The staff who oversee performing the experiments must 
be familiar with the proper animal care as well as the specific ways to bring up any concern to the 
IACUC. The IACUC has a special board which oversees receiving the complaints and 
investigating them. 
6.2.6 Health and Safety Issues  
There are many ways that a new topical wound care product can help patients with their health and 
safety issues. Some ways can include improving their self-esteem by calming them and reducing 
any negativity they may be holding in. This is important since stress has a major impact in wound 
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healing. When a patient is stressed or anxious their wound healing process will be impaired. Stress 
will impair cellular immunity, which compromises wound healing (Sen, 2019). Patients will not 
be as secure in applying a new topical product to their wound when they are aware that they contain 
chloroplasts in them.  
6.2.7 Manufacturability  
Since our product has potential in healing patients with wounds at a faster pace there are some 
limitations in manufacturing. The chloroplasts will require it to be under a light source to activate 
it. When it is under ambient light the reaction process takes a longer time. Materials, equipment, 
and labor will be required for isolating the chloroplasts and combining toe materials together.  
6.2.8 Sustainability  
Since our product is almost completely naturally-made the only materials required to produce the 
hydrogels are spinach leaves, glycerol and PBS. When fabricating these gels, you will also need 
pipettes, plastic and glass tools, ceramic mortar and pestle. These materials do not operate on using 
renewable energy. In contrast to this, the production of this will require little to no energy as well 
as it can be stored in a refrigerator until it will be used. If the materials used were to be disposable 
and use renewable energy than this will be more sustainable to the environment as well as it will 
help the environment and not harm it.   
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Chapter 7 Discussion 
The goal of this project was to develop a method of utilizing the functions of chloroplasts 
to naturally produce oxygen and promote wound healing. Our results have shown that amongst all 
the preliminary design choices, glycerol was the best fit to meeting our design objectives and 
constraints. As mentioned beforehand, glycerol is colorless, odorless and most importantly, non-
toxic. As it is not harmful to the human skin, this design choice met our criteria for developing a 
safe method to host the chloroplasts for oxygen delivery. Despite the lack of in-depth knowledge 
of the role of oxygen in the molecular and cellular level, studies have shown that oxygen does play 
a major role in the process of wound healing. 
As our testing has shown that the chloroplasts were able to sustain their functions and 
continue to produce oxygen per the Hill Reaction, this design choice considers both the objectives 
of taking advantage of oxygen and the constraints of maintaining safety and ease of use. It was 
clear that our testing with using Vaseline to host our chloroplast suspension was unfit for our 
standards to the heterogeneous mixture it resulted in. This is due to the hydrophilic properties of 
petroleum jelly which meant it was insoluble with our experimental chloroplast solution. The 
choice of hand sanitizer was able to host the chloroplast suspension temporarily as the alcohol 
started to kill off the chloroplasts after 1-2 days. Hence, this choice also did not meet our design 
standards despite being able to mix homogeneously with the chloroplast suspension. It was 
important to note how the results came about with the hand sanitizer mix. Our team had expected 
the chloroplasts to not survive for more than 24 hours in the mixture. The reasoning behind using 
hand sanitizer in the first place was to test how the chloroplast suspension would mix with the 
sanitizer solution at room temperatures. The mixture turned out to be homogeneous as expected, 
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but the team did not expect the chloroplasts to survive as long as it did in testing (1-2 days) when 
taking note of the high alcohol concentration. 
Upon choosing our final design with glycerol as the material of choice, our team has to 
reflect upon our objectives and constraints to understand to what extent the choice of glycerol 
meets our criteria. After reviewing those conditions, glycerol appeared to satisfy the criteria 
without any drastic consequences. The choice of glycerol was able to contain the chloroplast 
suspension in a homogeneous mixture, is non-toxic, and has the potential to be cost-effective with 
our design protocol.  
In regard to comparing our experimental results with other literature, it seems that there 
doesn’t exist in-depth studies about chloroplasts and oxygen production. We were unable to 
directly analyze how efficient the oxygen production in the chloroplasts were due to the lack of 
existing research. However, it is important to note that based on our observations regarding our 
trial results, we can definitively conclude that oxygen production was present per the Hill Reaction 
as the chloroplasts were able to conduct photosynthesis with and without a concentrated light 
source. This portrays evidence that the chloroplasts still continue to function even after being 
extracted and suspended in a different environment.  
 Over the course of conducting these trials for chloroplast activity, we had acknowledged 
the limitations of our experiment. As mentioned previously, there were no in-depth studies 
announcing the volume and efficiency of oxygen production in chloroplasts, even more so with 
chloroplasts extracted from spinach leaves in our case. Furthermore, we realized that the trials we 
conducted only tested for extended chloroplast activity for no longer than a week. One of our 
design objectives was to develop a product that has an extended shelf life of up to 6 months in 
order to compete with existing products in the market. Although our results have its shortcomings 
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of being unable to accurately determine how long the chloroplasts will survive long after 
production of the product for wound healing, we did acquire data in that chloroplasts can still 
function and produce the oxygen needed for the wound healing process. Our data successfully 
reports that chloroplasts will continue to conduct photosynthesis and portray the Hill Reaction 
post-extraction. 
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Chapter 8 Conclusion 
 The team’s final design selection was in favor of proceeding with utilizing glycerol as the 
main component in hosting a chloroplast suspension for oxygen production and delivery. This 
decision was due to glycerol satisfying our criteria without any major consequences within our 
scope. Our results yielded a positive outcome as it was determined that it is possible to maintain 
the chloroplasts’ functionality outside its natural environment. Unfortunately, the team was unable 
to produce a fully working product, as our scope focused on designing a protocol of utilizing the 
chloroplasts for wound treatment. The following discussion presents recommendations for 
overcoming our project limitations as well as future methods for realizing the successful 
production of our novel chloroplast-based method for wound treatment. This chapter will also 
reflect on the actions and tasks left undone due to certain circumstances, in hopes of pointing out 
another approach to solving the problem or improving upon our current work. 
8.1 Future Work 
For any type of future work or experiments there are some new modifications that can work with 
this product. Some future work that may be performed is by experimenting with different ratio of 
glycerol. For the three-experiment mention that were previously mentioned there was only a one-
to-one ratio of glycerol to the chloroplast solution. For the future work more ratios can be used 
more tests as well can be performed in order to measure the about of oxygen that is being released 
from the chloroplasts. Other future works that can be done on this product is different testing on a 
cell culture as well as on animals. For the cell culture there can be an experiment where a wound 
is performed on the cells and the product will be added to determine its rate of healing.  
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8.2 Recommendations 
Through the various experiments previously mentioned, the team was able to determine which 
methods work best for the product. The modifications were made in order to improve the product's 
validity. The following is a recommendation that we advise in order to better the design of our 
product. This recommendation will help the product be safer and more viable for patients to use.  
8.2.1 Disinfection and Sterilization 
When a product is sterilized it adds to the validity of the product as well as it makes it safer for 
patients to use. There are many ways to sterilize a product and maintain its full capability. In 
appendix B it is shown the difference between sterilization and disinfecting a product. Sterilization 
is using chemicals, heat, pressure, filtration, and irradiation. Disinfection uses detergent, alcohols, 
bleach, as well as heating and pasteurization. Disinfection is less sterile than when you sterilize a 
product. This is because disinfection kill bacteria another small living organism that produce 
disease. While sterilization is the destruction of all microorganisms. In the image below it shows 
the ranking of sterilization and disinfection. Here it is also seen that sterilization is ranked better 
than disinfection, but prion reprocessing is higher and better than sterilization. 
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Figure 8-1 Ranking the Bacteria Killed (CDC, 2016) 
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Appendices 
Appendix A: B-term Gantt Chart 
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Appendix B: Sterilization vs Disinfection 
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Appendix C: Microscope Images Hand Sanitizer (40x) 
 (Experiment 1) 
 (Experiment 2) 
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 (Experiment 3) 
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Appendix D: Chloroplast Solution (20x) 
 (Experiment 1) 
 (Experiments 2) 
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 (Experiment 3) 
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Appendix E: Materials Needed 
 
Spinach Leaves 
 
PBS Solution 
 
DCPIP Solution 
 
Mortar and Pestle 
 
Coffee Filter Sheets  
Centrifuge 
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Micropippete 
 
Glass Funnel 
 
Centrifuge Tubes  
Microcentrifuge Tubes 
 
